The PTEN hamartoma tumor syndrome (PHTS) is a heterogeneous set of multisystem disorders caused by germline pathogenic variants in the PTEN tumor suppressor gene. Manifestations include developmental anomalies and proliferative lesions. Evidence of involvement of the GI tract has accrued over time, leading to the incorporation of GI manifestations (multiple hamartomas, glycogenic acanthosis and colorectal cancer) into the diagnostic criteria. Polyps of the upper and lower GI tract are found in most adult patients and in a significant fraction of children. Polyps tend to be of mixed histology, with a predominance of hamartomas and ganglioneuromas. PHTS patients are also at increased risk of colorectal cancer, and surveillance by colonoscopy is advised starting at the age of 35–40 years. A number of additional manifestations, including eosinophilic gastrointestinal disorders, have been observed in few or single cases, and their association with PHTS has yet to be determined.

D'Emo, G., Genuardi, M., Gastrointestinal manifestarions in PTEN hamartoma tumor syndrome., <<BAILLIERE'S BEST PRACTICE & RESEARCH. CLINICAL GASTROENTEROLOGY>>, 2022; 2022 (2022): 58-59 [https://hdl.handle.net/10807/219700]

Gastrointestinal manifestarions in PTEN hamartoma tumor syndrome.

Genuardi, Maurizio
2022

Abstract

The PTEN hamartoma tumor syndrome (PHTS) is a heterogeneous set of multisystem disorders caused by germline pathogenic variants in the PTEN tumor suppressor gene. Manifestations include developmental anomalies and proliferative lesions. Evidence of involvement of the GI tract has accrued over time, leading to the incorporation of GI manifestations (multiple hamartomas, glycogenic acanthosis and colorectal cancer) into the diagnostic criteria. Polyps of the upper and lower GI tract are found in most adult patients and in a significant fraction of children. Polyps tend to be of mixed histology, with a predominance of hamartomas and ganglioneuromas. PHTS patients are also at increased risk of colorectal cancer, and surveillance by colonoscopy is advised starting at the age of 35–40 years. A number of additional manifestations, including eosinophilic gastrointestinal disorders, have been observed in few or single cases, and their association with PHTS has yet to be determined.
2022
AREA06 - SCIENZE MEDICHE
Pubblicazione su rivista con Impact Factor
Inglese
Articolo in rivista
Inglese
PTEN
Settore MED/03 - GENETICA MEDICA
2022
2022
2022
58
59
2
Articolo su rivista scientifica / specializzata
info:eu-repo/semantics/article
D'Emo, G., Genuardi, M., Gastrointestinal manifestarions in PTEN hamartoma tumor syndrome., <<BAILLIERE'S BEST PRACTICE & RESEARCH. CLINICAL GASTROENTEROLOGY>>, 2022; 2022 (2022): 58-59 [https://hdl.handle.net/10807/219700]
none
262
D'Emo, G.; Genuardi, Maurizio
2
art_per_29
03. Contributo in rivista::Articolo in rivista, Nota a sentenza
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/219700
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact